Altone

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Altone

Altone: Definition and Composition as a Synthetic Agent

Property Description
Active ingredient Spironolactone
Form Oral Tablet, Oral Suspension
Pharmacological class Aldosterone Antagonist
Common use Management of volume and pressure imbalances
Origin Synthetic organic compound

Altone is a prescription medication formulated with the single active ingredient, Spironolactone (INN). This substance is a synthetic organic molecule designed for oral administration, typically available in the form of an oral tablet or oral suspension. This synthetic compound is the medicinal core of the product, distinguishing it from agents derived from natural sources, and is known to be metabolized into active forms like Canrenone, which mediate many of its effects.

What is the Pharmacological Class of Altone?

Altone is formally classified within the drug class of Aldosterone Antagonists, and functionally as a Potassium-Sparing Diuretic. This dual classification reflects its unique mechanism of action, which involves competitive binding to aldosterone receptors in the kidneys. The defining characteristic of Altone is its role as a Potassium-Sparing Diuretic, ensuring that while the body excretes excess sodium and water, it significantly reduces the corresponding loss of potassium.

This pharmacological action facilitates the elimination of excess water and sodium from the body while minimizing potassium loss, which is a key function in electrolyte management. This particular action is clinically recognized for its benefit in scenarios where maintaining potassium levels is essential.

General Purpose of Altone in Fluid Management

The general purpose of Altone is to achieve and maintain stable fluid and salt equilibrium within the circulatory system. By inhibiting the action of the mineralocorticoid aldosterone, which normally signals the body to retain salt and water, Altone facilitates the excretion of excess volume. This reduction in overall fluid and salt burden on the body is the fundamental benefit of the medication, supporting the stabilization of blood pressure and assisting in the management of physiological conditions characterized by volume overload.

What side effects are possible with Altone?

Possible Side Effects and Safety Information

The safety profile of Altone, which contains the active ingredient Spironolactone, is officially defined by its effects on fluid balance and various organ systems, as documented in regulatory labeling. The most prominent safety concern detailed in U.S. labeling, often highlighted in a Boxed Warning, is the risk of Severe Hyperkalemia (high blood potassium), a potentially life-threatening event, particularly in patients with impaired kidney function.


Adverse Reaction Classifications

Side effects are categorized by frequency and the body system affected. Hyperkalemia is classified as Very Common (ge 1/10). Common (ge 1/100 to < 1/10) adverse reactions often involve the Reproductive System (e.g., Gynecomastia in males, which is officially linked to both dosage level and duration of therapy) and the Nervous System (e.g., dizziness and lethargy).

  • Uncommon reactions include confusional states and urticaria.
  • Reactions of Frequency Not Known include severe cutaneous adverse reactions (SCARs) such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), as well as blood disorders like agranulocytosis.

Safety-Related Restrictions

Regulatory documents specify safety constraints, noting that Altone is generally contraindicated in individuals with pre-existing Hyperkalemia, Addison’s disease, or significant renal compromise (acute renal insufficiency or anuria). Concomitant use with other agents that increase potassium is explicitly noted as significantly raising the risk of severe hyperkalemia. Due to these risks, periodic monitoring of serum electrolytes and renal function is a core regulatory requirement.

Overdose and Emergency Response

Altone overdosage is officially documented to present with systemic manifestations, including drowsiness, mental confusion, dizziness, nausea, vomiting, and diarrhea. Specific findings may also include a maculopapular or erythematous rash. These acute manifestations are detailed in regulatory prescribing information.

The most critical regulatory concern involves the potential for severe metabolic complications, particularly hyperkalemia (elevated potassium levels). This electrolyte imbalance is officially associated with the risk of cardiac irregularities which may be fatal. Patients with pre-existing impaired renal function or severe liver disease are noted to have an increased vulnerability to these life-threatening consequences, including hepatic coma in at-risk individuals. Hyponatremia and reversible hyperchloraemic metabolic acidosis are also documented laboratory findings in overdose.

In any suspected case of overdosage, the official regulatory requirement is to seek immediate medical attention. The documented procedure for managing acute overexposure involves supportive treatment aimed at maintaining hydration, electrolyte balance, and vital functions. Regulatory documents explicitly state that no specific antidote is known. Measures described for gastrointestinal decontamination may include inducing vomiting or evacuating the stomach by lavage.

Therapeutic Uses of Altone

What Altone Treats: Main Uses and Benefits

Altone is generally used to help manage symptoms related to systemic imbalance and heightened physiological activity across several key therapeutic areas.


Symptom Relief and Therapeutic Context

This medication is commonly used to address symptoms that create noticeable physiological strain from fluid retention. This includes generalized swelling (edema) and ascites in conditions where functional stability becomes affected, such as liver cirrhosis and heart failure. It is also relevant for easing symptoms related to systemic imbalance in patients with resistant high blood pressure and those needing support for primary hyperaldosteronism.

The therapy plays a role in managing low potassium levels (hypokalemia) induced by other diuretics, which assists with maintaining functional stability and supports general well-being during symptomatic phases.


“The primary goal of this therapy is to support the body’s ability to achieve and maintain better control over fluid levels and pressure, which contributes to improved comfort during symptomatic periods.”


Quick Fact: Therapeutic Domains

This medication may assist with easing physical discomfort from fluid accumulation. It is relevant when supportive symptom management is appropriate for conditions characterized by periods of heightened symptoms related to volume and pressure imbalance. Altone is often used during phases when symptoms become more noticeable to help ease the overall symptom burden.

Regulatory References

  1. U.S. National Institutes of Health (NIH) data on Spironolactone

Eligibility and Restrictions for Use

Eligibility and Contraindications

Altone's eligibility for use is strictly defined by regulatory documents based on patient population and pre-existing conditions. The medicine is authorized for use in adults with labeled conditions such as certain forms of edema, essential hypertension, severe heart failure, and primary hyperaldosteronism.

The medication is contraindicated and must not be used in patients with Hyperkalemia (high serum potassium levels), Addison’s disease, or acute renal insufficiency and Anuria. Regulatory labels also prohibit use in individuals receiving Eplerenone concurrently.

Restrictions and Special Populations

Eligibility is limited by specific physiological measures. For instance, in severe heart failure, use is prohibited if serum potassium exceeds 5.0 mEq/L or if serum creatinine exceeds defined thresholds. The safety and efficacy have not been established in the pediatric population. Older adults and patients with impaired hepatic function require special caution and monitoring.

Use during pregnancy is restricted due to the potential risk of affecting sex differentiation in the male fetus, necessitating a clinical risk-benefit assessment. During lactation, a decision is required to either discontinue the drug or discontinue breastfeeding.

What should I know about interactions with other medicines?

Altone (Spironolactone) is a potassium-sparing diuretic, and its primary concern for drug interactions is the risk of elevated potassium levels (hyperkalemia) when combined with other agents that also raise serum potassium. This is considered a clinically significant risk.

Major Interaction Concerns

  • Potassium-Elevating Drugs: Concomitant use with potassium supplements, salt substitutes, and other agents that retain potassium—such as ACE inhibitors (e.g., lisinopril), Angiotensin II Receptor Blockers (ARBs) (e.g., valsartan), heparin, or the antibiotic trimethoprim—substantially increases the risk of severe hyperkalemia.
  • Eplerenone: Use with the potassium-sparing diuretic eplerenone is generally contraindicated due to the high risk of severe hyperkalemia.
  • NSAIDs: Nonsteroidal Anti-inflammatory Drugs (NSAIDs) like ibuprofen or naproxen may reduce Altone’s diuretic and blood pressure-lowering effects, in addition to contributing to the risk of hyperkalemia and potential kidney issues.

Other Notable Interactions

  • Lithium: Altone may reduce the renal clearance of lithium, leading to increased plasma levels and a higher risk of lithium toxicity.
  • Digoxin: Altone can interfere with certain laboratory tests for digoxin, potentially causing misleading results, and may also increase the actual effects of digoxin in the body.
  • Cholestyramine: Concomitant use has been associated with hyperkalemic metabolic acidosis.

Mechanism of Action

Altone (spironolactone) is a mineralocorticoid receptor antagonist that acts through its primary mechanism of receptor competitive binding and secondary non-mineralocorticoid receptor engagement.


Aldosterone Receptor Antagonism

Altone engages with aldosterone receptors (Mineralocorticoid Receptors or MRs) primarily located in the renal collecting ducts. By competitively occupying the MR binding site, Altone blocks the transcriptional effects of endogenous aldosterone. This action suppresses the signaling cascade that normally leads to the expression of proteins responsible for increased sodium and water reabsorption and potassium excretion.


Fluid and Electrolyte Pathway Modulation

Blocking the MR alters the downstream effects of aldosterone-mediated transcription, resulting in modified ion transport within the renal tubules. The physiological consequence is an increase in urinary excretion of sodium and water, concurrent with a decrease in potassium excretion and subsequent potassium retention.


Non-Mineralocorticoid Receptor Engagement

In addition to the primary target, Altone interacts with androgen receptors and progesterone receptors. These non-mineralocorticoid effects result in altered physiological responses related to secondary hormonal signaling pathways.

Dosage and Administration Information

How Altone (Spironolactone) is Used in Clinical Practice

Altone is administered exclusively via the oral route, available in both oral tablet and oral suspension forms. The dosage and administration schedule are highly dependent upon the specific medical condition being addressed.


Dosing Principles and Regimens

The usage of Altone is characterized by gradual titration, meaning the dose is adjusted slowly over time. For conditions such as essential hypertension, the initial adult dosage typically ranges from 50 mg to 100 mg daily, with adjustments occurring at two-week intervals. For severe heart failure, the standard starting dose is often 25 mg once daily, which may be subsequently adjusted to 50 mg daily or 25 mg every other day, with care taken not to exceed the established maximum daily dose. Patients with severe edema may be started on doses up to 100 mg daily, which can be further increased up to 400 mg daily in cases of hepatic cirrhosis.


Administration Conditions and Special Populations

Consistency is emphasized in administration relative to food intake. The medication should always be taken either with a meal or without one, as food can increase the body’s absorption of the active ingredient. For the oral suspension, the liquid must be shaken thoroughly before use.

For specific patient groups, including older adults and those with renal or hepatic impairment, therapy is initiated at the lowest possible dose. Pediatric dosing is determined based on the patient's body weight, and requires specialized medical guidance. Therapy often involves long-term maintenance for chronic conditions like heart failure and hypertension, requiring ongoing adherence to the prescribed frequency and dose.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Altone

Evidence for Use in Managing Severe Heart Failure

Research exploring Altone’s role in managing severe heart failure with reduced ejection fraction has primarily involved large-scale, long-term Randomized Controlled Trials (RCTs). These long-term studies, often cited by regulators, were conducted as RCTs where patients received Altone as an add-on to standard care compared against those receiving standard care plus a placebo. Researchers monitored crucial clinical outcomes related to physiological strain, such as all-cause mortality and the frequency of cardiovascular hospitalization, and functional measures that these studies focused on in adults with severe heart failure.

Findings from these primary trials describe patterns indicating a difference in the observed rates of all-cause mortality and heart failure-related hospitalization events in the Altone group compared to the comparator group. The research protocols for all participants consistently documented monitoring of potassium and kidney function as a required part of the study. Despite the comprehensive data, evidence remains limited for certain smaller subgroups, such as patients with pre-existing kidney issues.

Evidence for Fluid Management in Liver Cirrhosis

Research examined Altone’s role in fluid management and salt balance in adults with liver cirrhosis, a condition characterized by high fluid volume and systemic imbalance. The research includes Controlled Clinical Studies and Observational Cohorts that explored Altone's utility, often within a combination regimen with other diuretic agents. The research examined physiological outcomes such as the rate of fluid excretion (diuresis) and the maintenance of potassium levels.

Reported observations indicate that varied dosing schedules were evaluated in some studies to achieve the measured fluid changes in this patient group. The reported evidence describes that laboratory monitoring to track electrolyte imbalances was a consistently observed component of the study protocols. What remains less characterized are the long-term outcomes for patients with the most advanced stages of cirrhosis.

Evidence in Specific Groups of Patients and Study Gaps

Research has explored the use of Altone in specific patient groups, including older adults, who were included in the main heart failure RCTs. Conversely, data for certain other groups remain insufficient. For the pediatric population, specific studies have been conducted, but results apply only to the populations studied and follow-up durations were limited in those specific trials. For heart failure with preserved ejection fraction (HFpEF), evidence quality varies across studies, with some primary outcomes showing mixed findings, meaning certainty remains low for some aspects of its use in this population.

Key Studies & References

  1. The Prescription Characteristics, Efficacy and Safety of Spironolactone in Real-World Patients With Acute Heart Failure Syndrome: A Prospective Nationwide Cohort Study
  2. Aldosterone Inhibitors in Infants and Children (Review of Pediatric Use)

Frequently Asked Questions (FAQ)

Common questions about Altone (FAQ)

Q: Is Altone a long-term treatment or short-term?

According to official product information, therapy with Altone is often required for long-term maintenance, particularly for chronic conditions like severe heart failure and essential hypertension. This reflects the need for ongoing management of volume and pressure imbalances in these conditions.

Q: Are there any known common side effects of Altone that people discuss online?

Official sources report several adverse reactions as common (meaning they occur in 1 in 100 to 1 in 10 people). These commonly reported effects include conditions like gynecomastia (enlargement of breast tissue in males), dizziness, and general lethargy. These are the main effects described in regulatory documents.

Q: Is it normal to feel [vague sensation, e.g., slightly tired] when first taking Altone?

The official product labeling indicates that mild fatigue, such as drowsiness or lethargy, is a reported adverse effect. If this symptom is experienced, it is consistent with the drug’s known safety profile. Concerns regarding any symptoms should be raised with a healthcare provider.

Q: What kind of interactions does Altone have with common vitamins or supplements?

Regulatory documents describe a potential interaction risk with supplements high in potassium, such as some salt substitutes, and caution is warranted due to the risk of severe hyperkalemia (dangerously high potassium levels in the blood). The focus of this warning is on minimizing the intake of extra potassium.

Q: Can Altone be taken with everyday pain relievers like [Pain Reliever name]?

Official warnings note that Non-Steroidal Anti-inflammatory Drugs (NSAIDs), such as ibuprofen or naproxen, may increase the risk of side effects and reduce Altone’s effect. However, the regulatory documents do not note a major drug-drug interaction warning specifically for common pain relievers like Acetaminophen.

Q: What happens if a person misses a dose of Altone?

Official patient guidance often describes taking a missed dose as soon as it is remembered. However, if it is close to the time of the next scheduled dose, the missed dose is typically skipped entirely. The guidance specifies that two doses should not be taken together.

Q: Is Altone safe for use in older adults (seniors)?

Altone is authorized for use in older adults. However, due to an increased risk of certain adverse effects in this population, regulatory documents recommend initiating therapy at the lowest possible dose. Ongoing clinical monitoring is a required component of treatment for this group.

Q: Is it true that Altone is sometimes used for [Broad, non-specific condition/symptom]?

Altone is authorized by regulatory agencies only for the specific, labeled conditions, which include heart failure, essential hypertension, primary hyperaldosteronism, and certain types of edema. The official labelling specifies these conditions and does not include other broad or non-specific conditions.

Q: How does Altone affect blood pressure or heart rate?

The drug is approved for the management of high blood pressure (hypertension) and plays a role in stabilizing the heart in cases of severe heart failure. By controlling fluid balance and reducing volume overload, Altone supports the stabilization of blood pressure and cardiovascular function.

Q: What do researchers mean when they talk about the 'pharmacodynamics' of Altone?

Pharmacodynamics is the official term for how a drug acts on the body. Altone works by blocking receptors in the kidney responsible for retaining salt and water, which in turn leads to increased sodium and water excretion while minimizing potassium loss. This action is the core of its therapeutic effect.

Q: Is it possible to be allergic to Altone?

Regulatory labeling indicates that severe hypersensitivity reactions, including anaphylaxis and severe skin reactions (SJS/TEN), have been reported in association with Altone use. These are considered uncommon or rare events, and official documentation details these risks.

Q: How often do people report rare side effects of Altone?

Side effects in official labeling are categorized by how often they occur, using terms like 'Common,' 'Uncommon,' or 'Frequency Not Known.' Those classified as 'Frequency Not Known' are typically severe or rare events that are reported voluntarily, making it difficult to calculate an exact reporting rate for the general population.

Q: Does Altone affect sleep patterns?

Official product information lists drowsiness and lethargy as effects on the nervous system. Since these effects are reported, they have the potential to indirectly affect sleep patterns. Concerns about persistent changes in sleep quality should be discussed with a healthcare professional.

Q: Can Altone cause mood changes or mental fog?

Side effects reported under the nervous system in regulatory documents include states of mental confusion and ataxia (which describes a loss of full control of bodily movements). While these effects can feel like mood changes or mental fog, they are officially recognized as specific neurological adverse reactions.

Q: What does official research say about the long-term use of Altone?

The safety and efficacy of Altone have been examined in long-term Randomized Controlled Trials (RCTs) for severe conditions like heart failure. These studies provide the clinical evidence base for long-term use, primarily by monitoring clinical outcomes such as mortality and hospitalization rates over extended periods.

Q: Is Altone safe to use during pregnancy or breastfeeding, according to official warnings?

Official warnings note that use during pregnancy is restricted because of the potential for the drug to affect the development of a male fetus. When a person is breastfeeding, caution is required because the drug is known to be present in breast milk. The decision to use Altone during these periods requires a clinical assessment of risk versus benefit.

Q: What does the regulatory labeling say about driving or operating machinery while on Altone?

Regulatory documents include a warning that side effects associated with the drug, particularly dizziness or drowsiness, may impair a person's ability to drive or operate complex machinery safely. Individuals may need to exercise caution until they understand how the medication affects their ability to perform these tasks.

Q: What makes Altone different from similar medicines in its class?

Altone is officially described as a non-selective mineralocorticoid receptor antagonist. This means that in addition to its primary action on aldosterone receptors in the kidney, it is also known to interact with androgen and progesterone receptors. This characteristic defines its non-selective mechanism compared to other drugs in its class.

Q: Are there any specific foods or drinks that should be avoided while using Altone?

Yes, there is a caution regarding alcohol use, which should be avoided or limited as it can increase the risk of side effects like dizziness and low blood pressure. Additionally, potassium-rich foods must be managed to avoid the risk of hyperkalemia (high potassium), as noted in regulatory warnings.

Q: What is the difference between Altone and the generic version of the medicine?

The generic version contains the identical active ingredient, Spironolactone, as the brand name product, Altone. Regulatory bodies require generic medications to meet the same strict quality, strength, purity, and performance standards as the original drug.

Q: Are there any known interactions between Altone and alcohol?

Yes, regulatory sources warn of a potential interaction between Altone and alcohol. Taking them together may lead to an additive blood pressure lowering effect, which can increase the risk of side effects such as dizziness or fainting.

Q: Is Altone considered a scheduled or controlled substance?

According to the major regulatory bodies that schedule medications for potential abuse or dependence, Altone (Spironolactone) is typically not classified as a controlled substance. It is a prescription diuretic and aldosterone antagonist.

Q: What is the general success rate mentioned in the clinical studies for Altone?

Clinical studies do not typically report a single 'success rate' percentage for Altone, but rather measure specific patient outcomes. The evidence for heart failure, for example, reports observed reductions in all-cause mortality and heart failure-related hospitalization rates compared to a placebo group.

Q: Is Altone a new drug or has it been on the market for a long time?

Altone, which contains the active ingredient Spironolactone, is considered an older medication. The drug was initially approved by the U.S. Food and Drug Administration (FDA) in the 1960s, meaning it has been in use for several decades.

Q: What kind of interactions does Altone have with herbal remedies?

Regulatory sources advise caution regarding herbal remedies and supplements that may contain high levels of potassium. Taking any product high in potassium concurrently with Altone increases the risk of severe hyperkalemia, which is a key safety concern.

How should Altone be stored and disposed of?

Storage and Disposal Requirements for Altone (Spironolactone)

Official Storage Conditions

Altone tablets must be stored at controlled room temperatures to maintain stability. The regulatory documents mandate storage below 77 F (25 C) or not above 30 C in certain regions. The tablets must be kept in the original carton to ensure they are protected from light.

Prepared Suspensions and Safety

If the medication is compounded into an oral suspension, it is stable for only one month and requires refrigeration (2 C to 8 C). All forms of Altone must be stored out of the reach of children and pets to prevent accidental ingestion.

Disposal Instructions

Unused or expired medicine should be disposed of by following the guidance for drug take-back programs. If a program is unavailable, governmental guidance recommends mixing the medicine with an undesirable substance, sealing it, and discarding it in the household trash, with local regulations governing waste management.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Altone found in:

A-Z Index: